SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: DaiS who wrote (21429)4/27/1999 9:01:00 AM
From: VLAD  Read Replies (2) | Respond to of 23519
 
GOOD MORNING FLOCK! ARE WE READY TO RUMBLE?

Looks like our pals at CRUT are going to be at it again today slowly accumulating shares for their institutional clients (first on the bid at 4 3/4 as I type).



To: DaiS who wrote (21429)4/27/1999 9:12:00 AM
From: Zebra 365  Respond to of 23519
 
<<<Did they say alprostadil?>

Sorry their patent says prostaglandin.

DaiS>>>

Alprostidil IS Prostaglandin E1

You can patent a new use for an old drug, haven't read the patent but probably was also for many potential vasodilators, like the patent for MUSE was a new use of an old generic drug, and does list many other potential drugs.

Zebra



To: DaiS who wrote (21429)4/27/1999 9:18:00 AM
From: VLAD  Read Replies (1) | Respond to of 23519
 
SHORT INTEREST NUMBERS FOR PERIOD ENDING 4-15-99

5,827,880 which is down from the prior month's 6,011,683.

Don't forget that doesn't include trading on April 16 when we gapped up at 6 and traded down to 5 1/32 on 7.5M shares which probably saw some serious shorting.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News